Nov 16, 2026 • 4:01 PM EST Interpace Biosciences Announces Third Quarter 2026 Financial and Business Results
Oct 14, 2026 • 8:29 PM EDT Interpace Biosciences Announces Preliminary Unaudited Third Quarter 2026 Revenue
Aug 26, 2026 • 4:05 PM EDT Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting